K2M, SeaSpine, Blue Belt Technologies & more — 18 key notes

Anuja Vaidya -   Print  |

Here are 18 key notes on orthopedic and spine device companies over the past week.

Amedica reported a drop in product revenue for the third quarter due to a decline in the non-silicon nitride product sales.

 

Silver Lake Medical Center in Los Angeles has become the first hospital in the city to implement Blue Belt Technologies' Navio orthopedic surgical system.


 
Boston Scientific is testing its spinal cord stimulator app, My SCS Journey, in clinical trials.


 
CoorsTek Medical added Francesco Benazzo, MD, to its medical device and clinical materials advisory board.

 

GRAFTYS recently established a post-marketing surveillance program in the form of an internationally-based registry of patients.


   
K2M shares experienced a decrease of 27.7 percent in short interest during October 2015.

 

K2M CFO Gregory S. Cole sold 41,574 shares of stock in a recent transaction.


 
The United States Patent and Trademark Office granted KATOR a key patent related to its suture anchor technology.

 

LDR company shares dropped 11.25 percent the week of Nov. 9 to Nov. 13, and 10.18 percent in the last four weeks.

 

Medtech was honored by Deloitte In Extenso at the 15th Annual Technology Fast 50 Awards for the Mediterranean Area.


 
Nexxt Spine developed the DT Elite Guide System.


 
Nvision launched four initial proprietary products for distribution, focusing on the spine: Nv(c): anterior cervical interbody fusion system; Nv(t): transforaminal lumbar interbody fusion system; Nv(p): posterior lumbar interbody fusion system; and Nv(a): anterior lumbar interbody fusion system.

 

Shares of Orthofix have dropped 4.71 percent during the past week.


 
Prosidyan received FDA 510(k) clearance for its FIBERGRAFT BG Morsels for posterolateral spinal fusion.


 
SeaSpine reported a 3 percent revenue drop for the third quarter of 2015.

 

The Spine Center at Bone & Joint Clinic of Baton Rouge, La., is offering surgery with SI-Bone's iFuse implant.

 

Vertebral Technologies closed the first tranche of a $2.5 million Series B financing with the EB-5 immigrant investor program.

 

Zyga Technology completed a $20 million round of financing.

 

More articles on devices:
$5M donation to MUSC creates idea incubator; spine device is 1st project: 5 things to know
KATOR receives key patent for suture anchor device: 3 things to know
Dr. Kevin McCarthy performs iFuse surgery for back pain: 4 things to know

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers